Pharmaceutical Technology · 1h
Purdue and Sackler family agree to $7.4bn national opioid settlement
Purdue Pharma and its owners, the Sackler family, have reached a $7.4bn settlement with US states to resolve a long-running legal saga involving the pain medication Oxycontin and its role in fuelling the opioid epidemic in the country.
FiercePharma · 6h
Sackler family, Purdue Pharma boost multistate opioid settlement to $7.4B in new agreement
In the latest twist in its efforts to wrap up years of high-profile opioid litigation, the billionaire family behind the now-bankrupt Purdue Pharma, the Sacklers, has come back from last year’s Sup | The billionaire family behind former OxyContin maker Purdue Pharma was denied a bankruptcy protection deal in a high-profile Supreme Court ruling last summer.
The Financial Times · 20h
Purdue and Sackler family agree to $7.4bn opioid settlement with US states
The Sackler family and the opioid maker they founded, Purdue Pharma, have together agreed to pay $7.4bn to settle liabilities over their roles in the opioid crisis, ending months of negotiations after a previous deal fell apart.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results